Patent · US Active

Bicyclic compound that acts as CRBN protein regulator

US11905276B2 · kind B2 · utility

0Cited by
0References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 14, 2020
Grant dateFeb 20, 2024
Priority date
Expiry dateNov 3, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound represented by formula (III) or a pharmaceutically acceptable salt thereof, and disclosed is an application thereof in the preparation of a medication for treating diseases related to a CRBN receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.